Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib - results from a non-interventional multi-center study.
Christoph Benedikt WestphalenTobias KukiolkaBenjamin GarlippLars HahnMartin FuchsPeter MalfertheinerMarcel ReiserFabian KüttingVolker HeinemannAndreas BeringerDirk T WaldschmidtPublished in: BMC cancer (2020)
ClinicalTrials.gov Identifier: NCT01782690, retrospectively registered on 4 February 2013.